Loading insider details...
Beta
Latest Form 4 (Jun 3, 2025): Grant/Award of 55,000 NAMS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 55,000 | n/a |
| Sep 18, 2024 | OptiNose, Inc. (OPTN) | Sale | 3,226 | $2.8K |
| Jul 18, 2024 | OptiNose, Inc. (OPTN) | Sale | 49,408 | $56.3K |
| Jun 20, 2024 | OptiNose, Inc. (OPTN) | Sale | 2,946 | $3.5K |
| Jun 18, 2024 | OptiNose, Inc. (OPTN) | Grant/Award | 3,817 | n/a |
| Mar 19, 2024 | OptiNose, Inc. (OPTN) | Grant/Award | 3,816 | n/a |
| Feb 29, 2024 | OptiNose, Inc. (OPTN) | Grant/Award | 280,000 | n/a |